Cite
HARVARD Citation
Hernandez, G. et al. (n.d.). Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint. Alzheimer's & dementia. p. n/a. [Online].